Literature DB >> 18366183

Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules.

Jampani Nageswara Rao1, Varun Dua, Tobias S Ulmer.   

Abstract

The 140-residue protein alpha-synuclein (aS) has been implicated in the molecular chain of events leading to Parkinson's disease, which relates to the hierarchical aggregation of aS into soluble oligomers and insoluble fibrils. A number of small organic molecules have been reported to inhibit aS aggregation. Here, the interactions of chlorazole black E, Congo red, lacmoid, PcTS-Cu (2+), and rosmarinic acid with aS are examined by NMR spectroscopy to identify aS sequence elements that are masked by these compounds. Surprisingly, similar aS interaction sites, encompassing residues 3-18 and 38-51, were obtained for all molecules at equimolar small molecule:aS ratios. At higher ratios, virtually the entire amphiphilic region of aS (residues 2-92) is affected, revealing the presence of additional, lower affinity interaction sites. Upon rearranging the high-affinity interaction sites over the aS amphiphilic region in an aS mutant form, perturbations of the entire amphiphilic region were found to have already been obtained at equimolar ratios, indicating a high specificity for the original binding sites. CD spectroscopy reveals that, in the presence of the small molecules, the aS structure is still dominated by random-coil characteristics. The strongest effects are exerted by molecules that contain sulfonate groups adjacent to aromatic systems, often present in multiple copies in a symmetrical arrangement, suggesting that these elements are useful for developing an aS-specific chemical chaperone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366183     DOI: 10.1021/bi8002378

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins.

Authors:  Jampani Nageswara Rao; Christine C Jao; Balachandra G Hegde; Ralf Langen; Tobias S Ulmer
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

2.  Fluorescence spectroscopy reveals N-terminal order in fibrillar forms of α-synuclein.

Authors:  Conor M Haney; E James Petersson
Journal:  Chem Commun (Camb)       Date:  2018-01-18       Impact factor: 6.222

Review 3.  Agrochemicals, α-synuclein, and Parkinson's disease.

Authors:  Blanca A Silva; Leonid Breydo; Anthony L Fink; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-08-30       Impact factor: 5.590

Review 4.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

5.  A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Authors:  Shubhangi Prabhudesai; Sharmistha Sinha; Aida Attar; Aswani Kotagiri; Arthur G Fitzmaurice; Rajeswari Lakshmanan; Ravi Lakshmanan; Magdalena I Ivanova; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Mark Stahl; Gal Bitan; Jeff M Bronstein
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

6.  Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.

Authors:  J Ignacio Gallea; M Soledad Celej
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

7.  Computer simulations of protein-membrane systems.

Authors:  Jennifer Loschwitz; Olujide O Olubiyi; Jochen S Hub; Birgit Strodel; Chetan S Poojari
Journal:  Prog Mol Biol Transl Sci       Date:  2020-02-26       Impact factor: 3.622

8.  Transthyretin Mimetics as Anti-β-Amyloid Agents: A Comparison of Peptide and Protein Approaches.

Authors:  Kayla M Pate; Brandon J Kim; Eric V Shusta; Regina M Murphy
Journal:  ChemMedChem       Date:  2018-04-16       Impact factor: 3.466

9.  A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

Authors:  James A Hebda; Ishu Saraogi; Mazin Magzoub; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2009-09-25

10.  Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation.

Authors:  Gonzalo R Lamberto; Andrés Binolfi; María L Orcellet; Carlos W Bertoncini; Markus Zweckstetter; Christian Griesinger; Claudio O Fernández
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.